Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke - Current Treatment Options in Cardiovascular Medicine

Clicks: 147
ID: 268879
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #34 of 40 articles by views in current treatment options in cardiovascular medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Statins are a group of lipid-lowering agents that are competitive inhibitors of the enzyme 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase that have been used to reduce cholesterol levels and prevent cardiovascular events. Statins have been also shown to reduce the risk of stroke. In this review, we cover the role of statins in cerebrovascular disease through lipid-lowering mechanisms and other “pleiotropic” effects that provide protection against cerebrovascular events and potentially contribute to improve functional outcome after stroke.
Reference Key
shadi2016currentlipid Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yaghi, Shadi;Elkind, Mitchell S. V.;Yaghi, Shadi;Elkind, Mitchell S. V.;
Journal current treatment options in cardiovascular medicine
Year 2016
DOI
doi:10.1007/s11936-016-0448-8
URL
https://doi.org/10.1007/s11936-016-0448-8
Keywords
cardiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.